欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/0741/002
药品名称
Preglenix
活性成分
pregabalin 150.0 mg
剂型
Capsule, hard
上市许可持有人
Glenmark Pharmaceuticals s.r.o.
参考成员国 - 产品名称
Czechia (CZ)
PREGLENIX
互认成员国 - 产品名称
Slovakia (SK)
Preglenix 150 mg tvrdé kapsuly
许可日期
2015/06/24
最近更新日期
2024/03/07
药物ATC编码
N03AX16 pregabalin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
common_pl_clean_v020
Date of last change:2024/03/07
Final SPC
|
common_spc_clean_v020
Date of last change:2024/03/07
Final Product Information
|
common-lab-30092021-clean-r001-d40
Date of last change:2022/01/06
Final Product Information
|
common-pil-clean-r001-d60
Date of last change:2022/01/06
Final Product Information
|
common-spc-30092021-clean-r001-d40
Date of last change:2022/01/06
Final Labelling
|
Preg-common-lab-v006-clean
Date of last change:2018/07/20
PAR
|
PAR
Date of last change:2016/02/05
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase